Ethelberg, S., Lovmand, J., Schmidt, J., Luz, A., & Pedersen, F. S. (1997). Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Ethelberg, S., J. Lovmand, J. Schmidt, A. Luz, και F S. Pedersen. Increased Lymphomagenicity and Restored Disease Specificity of AML1 Site (core) Mutant SL3-3 Murine Leukemia Virus By a Second-site Enhancer Variant Evolved in Vivo. 1997.

Ethelberg, S., et al. Increased Lymphomagenicity and Restored Disease Specificity of AML1 Site (core) Mutant SL3-3 Murine Leukemia Virus By a Second-site Enhancer Variant Evolved in Vivo. 1997.